Literature DB >> 28042136

Epidemiology and treatment of hepatocellular carcinoma in Thailand.

Soonthorn Chonprasertsuk1, Ratha-Korn Vilaichone1.   

Abstract

Hepatocellular carcinoma (HCC) is the most frequent type of malignant liver tumor in Thailand. The high incidence rate of HCC reflects from chronic HBV infection in this endemic area. Some patients are asymptomatic at presentation whereas many of them presented at advanced stage of HCC with limited treatment options and grave outcome. The Barcelona Clinic Liver Cancer (BCLC) staging system and management allocation for HCC is widely accepted and used in many international guidelines including Thailand. Curative treatment is expected in early stage of HCC while palliative treatment, combination treatment and best supportive care are offered to advanced stage of HCC. The most effective strategy to prevent the development of HCC is prevention of HBV vertical transmission and treatment HBV or HCV infection. The purpose of this article is to update information of HCC in Thailand including epidemiology, diagnosis, clinical manifestation, and treatment.
© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Thailand; epidemiology; hepatocellular carcinoma (HCC); treatment

Mesh:

Year:  2017        PMID: 28042136     DOI: 10.1093/jjco/hyw197

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  11 in total

1.  Factors affecting prognosis in hepatocellular carcinoma patients post-transarterial chemoembolization.

Authors:  Tanaporn Prateepchaiboon; Arunchai Chang; Nuttanit Pungpipattrakul; Keerati Akarapatima; Attapon Rattanasupar; Apiradee Songjamrat; Songklod Pakdeejit; Teerha Piratvisuth
Journal:  Indian J Gastroenterol       Date:  2022-08-27

2.  Genome-Wide Association Study for Chronic Hepatitis B Infection in the Thai Population.

Authors:  Saeideh Ashouri; Seik-Soon Khor; Yuki Hitomi; Hiromi Sawai; Nao Nishida; Masaya Sugiyama; Yosuke Kawai; Nawarat Posuwan; Pisit Tangkijvanich; Piyawat Komolmit; Makoto Tsuiji; Vorasuk Shotelersuk; Yong Poovorawan; Masashi Mizokami; Katsushi Tokunaga
Journal:  Front Genet       Date:  2022-06-13       Impact factor: 4.772

3.  Natural disease progression and novel survival prediction model for hepatocellular carcinoma with spinal metastases: a 10-year single-center study.

Authors:  Phichayut Phinyo; Chonmavadh Boonyanaruthee; Permsak Paholpak; Dumneoensun Pruksakorn; Areerak Phanphaisarn; Apiruk Sangsin
Journal:  World J Surg Oncol       Date:  2020-06-20       Impact factor: 2.754

Review 4.  Animal Models of Hepatocellular Carcinoma Prevention.

Authors:  Ram C Shankaraiah; Laura Gramantieri; Francesca Fornari; Silvia Sabbioni; Elisa Callegari; Massimo Negrini
Journal:  Cancers (Basel)       Date:  2019-11-14       Impact factor: 6.639

5.  Validation of the "Six-and-Twelve" Prognostic Score in Transarterial Chemoembolization-Treated Hepatocellular Carcinoma Patients.

Authors:  Apichat Kaewdech; Pimsiri Sripongpun; Natcha Cheewasereechon; Sawangpong Jandee; Naichaya Chamroonkul; Teerha Piratvisuth
Journal:  Clin Transl Gastroenterol       Date:  2021-02-18       Impact factor: 4.488

6.  Hsa_circ_0008537 facilitates liver carcinogenesis by upregulating MCL1 and Snail1 expression via miR‑153‑3p.

Authors:  Ge Yang; Xianyong Li; Jingbo Liu; Shengjie Huang; Yaguang Weng; Jing Zhu; Daiqiong Lin; Ou Jiang
Journal:  Oncol Rep       Date:  2021-01-19       Impact factor: 3.906

7.  Factors that Affect the Surveillance and Late-Stage Detection of a Newly Diagnosed Hepatocellular Carcinoma.

Authors:  Attapon Rattanasupar; Supattra Chartleeraha; Keerati Akarapatima; Arunchai Chang
Journal:  Asian Pac J Cancer Prev       Date:  2021-10-01

8.  Clinical Features and Overall Survival of Females with Hepatocellular Carcinoma: A Retrospective Study and Review of the Literature in the Association of Southeast Asian Nations.

Authors:  Sarita Ratana-Amornpin; Ratha-Korn Vilaichone; Muhammad Miftahussurur; Natsuda Aumpan; Kittipong Kaewkarnjanarat; Pongjarat Nun-Anan; Soonthorn Chonprasertsuk; Sith Siramolpiwat; Patommatat Bhanthumkomol; Bubpha Pornthisarn; Tomohisa Uchida; Varocha Mahachai
Journal:  Int J Womens Health       Date:  2021-07-22

Review 9.  The Role of lncRNA PCAT6 in Cancers.

Authors:  Siying Wang; Zhenyao Chen; Jingyao Gu; Xin Chen; Zhaoxia Wang
Journal:  Front Oncol       Date:  2021-07-13       Impact factor: 6.244

10.  Knowledge, attitude, and behaviors toward liver health and viral hepatitis-related liver diseases in Thailand.

Authors:  Pochamana Phisalprapa; Tawesak Tanwandee; Boon-Leong Neo; Shikha Singh
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.